about
Endurance Exercise Enhances the Effect of Strength Training on Muscle Fiber Size and Protein Expression of Akt and mTOR.Influence of supplementation with branched-chain amino acids in combination with resistance exercise on p70S6 kinase phosphorylation in resting and exercising human skeletal muscle.Maximal lengthening contractions induce different signaling responses in the type I and type II fibers of human skeletal muscle.Acute low-load resistance exercise with and without blood flow restriction increased protein signalling and number of satellite cells in human skeletal muscle.Influence of nutrient ingestion on amino acid transporters and protein synthesis in human skeletal muscle after sprint exercise.High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptations to resistance training in young adults.Intake of branched-chain or essential amino acids attenuates the elevation in muscle levels of PGC-1α4 mRNA caused by resistance exercise.Leucine does not affect mechanistic target of rapamycin complex 1 assembly but is required for maximal ribosomal protein s6 kinase 1 activity in human skeletal muscle following resistance exercise.Activation of mTORC1 by leucine is potentiated by branched-chain amino acids and even more so by essential amino acids following resistance exercise.Resistance exercise-induced S6K1 kinase activity is not inhibited in human skeletal muscle despite prior activation of AMPK by high-intensity interval cycling.Absence of leucine in an essential amino acid supplement reduces activation of mTORC1 signalling following resistance exercise in young females.Intake of branched-chain amino acids influences the levels of MAFbx mRNA and MuRF-1 total protein in resting and exercising human muscleBenefits of higher resistance-training volume are related to ribosome biogenesismTORC1 Signaling in Individual Human Muscle Fibers Following Resistance Exercise in Combination With Intake of Essential Amino Acids
P50
Q35925987-1B3AAE90-C6E7-481D-844B-2DD91F503C48Q43042674-A16BA403-6878-4C8D-A3E5-362886EB64D3Q46181210-8FE69170-94BE-4061-B7F5-E5D07D5A119EQ46510746-43EF2434-1E97-47F5-9A94-0A2A00A5C43DQ47874211-E019311D-2859-41B4-AE0F-F77ADD09808BQ47915472-B133259B-1E45-4054-85AF-E0E199B9DF65Q51728269-6F921479-9900-41FF-9259-7E9874BBC173Q53428582-2B99013B-3F36-4D03-A2C0-C2384E3E94CDQ53790846-8F4F9441-85B0-40B6-AD00-50AAA49B2D58Q54295694-28C51937-2A69-4A8E-BDD9-F26678EB4C0EQ54323176-47DF98BE-E050-4F19-9416-BFD5837E435AQ82731563-82AF9EBC-9105-4208-82BA-FF745D76F6B1Q91778673-00EB8B9C-5CD7-418C-8A2B-8D25414944F2Q91786600-8C09614F-39F5-4FB9-A700-11BE829422C1
P50
description
researcher ORCID ID = 0000-0003-1942-2919
@en
wetenschapper
@nl
name
William Apró
@ast
William Apró
@en
William Apró
@es
William Apró
@nl
type
label
William Apró
@ast
William Apró
@en
William Apró
@es
William Apró
@nl
prefLabel
William Apró
@ast
William Apró
@en
William Apró
@es
William Apró
@nl
P31
P496
0000-0003-1942-2919